These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9351563)

  • 1. Results of hospital cancer registry surveys by the American College of Surgeons: outcomes of prostate cancer treatment by radical prostatectomy.
    Mettlin CJ; Murphy GP; Sylvester J; McKee RF; Morrow M; Winchester DP
    Cancer; 1997 Nov; 80(9):1875-81. PubMed ID: 9351563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.
    Walsh PC
    J Urol; 2000 Jun; 163(6):1802-7. PubMed ID: 10799186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate.
    Palisaar JR; Wenske S; Sommerer F; Hinkel A; Noldus J
    BJU Int; 2009 Sep; 104(5):611-5. PubMed ID: 19298408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database.
    Grossfeld GD; Chang JJ; Broering JM; Miller DP; Yu J; Flanders SC; Henning JM; Stier DM; Carroll PR
    J Urol; 2000 Apr; 163(4):1171-7; quiz 1295. PubMed ID: 10737489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
    Hedgepeth RC; Labo J; Zhang L; Wood DP
    J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.
    Penson DF; McLerran D; Feng Z; Li L; Albertsen PC; Gilliland FD; Hamilton A; Hoffman RM; Stephenson RA; Potosky AL; Stanford JL
    J Urol; 2005 May; 173(5):1701-5. PubMed ID: 15821561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA; Cooperberg MR; Elkin EP; Lubeck DP; Mehta SS; Kane CJ; Carroll PR
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications.
    Han M; Pound CR; Potter SR; Partin AW; Epstein JI; Walsh PC
    J Urol; 2001 Mar; 165(3):864-6. PubMed ID: 11176487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy after previous prostate surgery: clinical and functional outcomes.
    Colombo R; Naspro R; Salonia A; Montorsi F; Raber M; Suardi N; Saccà A; Rigatti P
    J Urol; 2006 Dec; 176(6 Pt 1):2459-63; discussion 2463. PubMed ID: 17085129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program.
    Varkarakis J; Pinggera GM; Sebe P; Berger A; Bartsch G; Horninger W
    Urology; 2004 Feb; 63(2):337-41. PubMed ID: 14972485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
    Carini M; Masieri L; Minervini A; Lapini A; Serni S
    Eur Urol; 2008 Mar; 53(3):554-61. PubMed ID: 17683854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy.
    Pierorazio PM; Spencer BA; McCann TR; McKiernan JM; Benson MC
    Urology; 2007 Oct; 70(4):717-22. PubMed ID: 17991543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncologic and functional outcomes after radical prostatectomy in T3 prostate cancer].
    Xylinas E; Misraï V; Comperat E; Renard-Penna R; Vaessen C; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M
    Prog Urol; 2009 May; 19(5):285-90. PubMed ID: 19393531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy.
    Kübler HR; Tseng TY; Sun L; Vieweg J; Harris MJ; Dahm P
    J Urol; 2007 Aug; 178(2):488-92; discussion 492. PubMed ID: 17561133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.